North America Veterinary Pain Management Market Size, Share & Industry Trends Analysis Report By Animal type (Livestock Animal and Companion Animal), By End-Use, By Indication, By Product, By Country and Growth Forecast, 2023 - 2030
The North America Veterinary Pain Management Market would witness market growth of 5.5% CAGR during the forecast period (2023-2030).
Veterinary treatment must have effective pain management. When pain is not properly managed in animals, sick animals experience increased stress and delayed healing. Animals may experience pain from operation, arthritis, or cancer, accompanied by discrimination, starvation, and reduced activity. This may hamper the productivity of agricultural and companion animals. Due to ongoing research on reducing chronic pain in animals, numerous methods are now available, including painkillers, physical therapy, acupuncture, laser therapy, and therapeutic massage.
Due to the rise in pet adoption as companions, which raises the demand for preventative care, medications, and veterinary healthcare facilities, the market has been expanding significantly. The prevalence of animal diseases that cause discomfort and inflammation is another factor driving market expansion. Additionally, it is projected that the increasing popularity of alternative and non-pharmaceutical treatments and untapped growing markets would offer additional growth opportunities.
The market in the North America region is anticipated to expand due to factors including growing adoption of pets and rising per capita spending on veterinary treatment for animals in the region. The primary cause of the market's expansion has been recognized as the increase in the occurrence of numerous animal diseases and injuries. The number of pets and livestock owners in the US has increased, and people have become more aware of the welfare of these animals. Therefore, the market is anticipated to experience considerable growth over the forecast period in North America due to the increasing awareness of and spending on animal health. The prevalence of inflammatory disorders in animals is increasing, along with all of the above factors; thus, the market is projected to expand over the coming years.
The US market dominated the North America Veterinary Pain Management Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $625 million by 2030. The Canada market is poised to grow at a CAGR of 7.9% during (2023 - 2030). Additionally, The Mexico market would witness a CAGR of 6.9% during (2023 - 2030).
Based on Animal type, the market is segmented into Livestock Animal and Companion Animal. Based on End-Use, the market is segmented into Hospitals & Clinics and Others. Based on Indication, the market is segmented into Osteoarthritis, Post-operative pain, and Others. Based on Product, the market is segmented into NSAIDs, Opioids, Anesthetics and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Boehringer Ingelheim International GmbH, Bayer AG, Zoetis, Inc., Merck & Co., Inc., Elanco Animal Health, Inc., Zomedica Corp. (Assisi Animal Health), Norbrook Laboratories Limited, Ceva Santé Animale, Dechra Pharmaceuticals PLC, and Vetoquinol SA (Soparfin SCA)
Scope of the Study
Market Segments covered in the Report:
By Animal type
- Livestock Animal
- Companion Animal
- Hospitals & Clinics
- Others
- Osteoarthritis
- Post-operative pain
- Others
- NSAIDs
- Opioids
- Anesthetics
- Others
- US
- Canada
- Mexico
- Rest of North America
- Boehringer Ingelheim International GmbH
- Bayer AG
- Zoetis, Inc.
- Merck & Co., Inc.
- Elanco Animal Health, Inc.
- Zomedica Corp. (Assisi Animal Health)
- Norbrook Laboratories Limited
- Ceva Santé Animale
- Dechra Pharmaceuticals PLC
- Vetoquinol SA (Soparfin SCA)
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Veterinary Pain Management Market, by Animal type
- 1.4.2 North America Veterinary Pain Management Market, by End-Use
- 1.4.3 North America Veterinary Pain Management Market, by Indication
- 1.4.1 North America Veterinary Pain Management Market, by Product
- 1.4.2 North America Veterinary Pain Management Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market at a Glance
- 2.1 Key highlights
- Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.3 Porter Five Forces Analysis
- Chapter 4. Strategies Deployed in Veterinary pain management Market
- Chapter 5. North America Veterinary Pain Management Market by Animal type
- 5.1 North America Livestock Animal Market by Country
- 5.2 North America Companion Animal Market by Country
- Chapter 6. North America Veterinary Pain Management Market by End-use
- 6.1 North America Hospitals & Clinics Market by Country
- 6.2 North America Others Market by Country
- Chapter 7. North America Veterinary Pain Management Market by Indication
- 7.1 North America Osteoarthritis Market by Country
- 7.2 North America Post-operative pain Market by Country
- 7.3 North America Others Market by Country
- Chapter 8. North America Veterinary Pain Management Market by Product
- 8.1 North America NSAIDs Market by Country
- 8.2 North America Opioids Market by Country
- 8.3 North America Anesthetics Market by Country
- 8.4 North America Others Market by Country
- Chapter 9. North America Veterinary Pain Management Market by Country
- 9.1 US Veterinary Pain Management Market
- 9.1.1 US Veterinary Pain Management Market by Animal type
- 9.1.2 US Veterinary Pain Management Market by End-use
- 9.1.3 US Veterinary Pain Management Market by Indication
- 9.1.4 US Veterinary Pain Management Market by Product
- 9.2 Canada Veterinary Pain Management Market
- 9.2.1 Canada Veterinary Pain Management Market by Animal type
- 9.2.2 Canada Veterinary Pain Management Market by End-use
- 9.2.3 Canada Veterinary Pain Management Market by Indication
- 9.2.4 Canada Veterinary Pain Management Market by Product
- 9.3 Mexico Veterinary Pain Management Market
- 9.3.1 Mexico Veterinary Pain Management Market by Animal type
- 9.3.2 Mexico Veterinary Pain Management Market by End-use
- 9.3.3 Mexico Veterinary Pain Management Market by Indication
- 9.3.4 Mexico Veterinary Pain Management Market by Product
- 9.4 Rest of North America Veterinary Pain Management Market
- 9.4.1 Rest of North America Veterinary Pain Management Market by Animal type
- 9.4.2 Rest of North America Veterinary Pain Management Market by End-use
- 9.4.3 Rest of North America Veterinary Pain Management Market by Indication
- 9.4.4 Rest of North America Veterinary Pain Management Market by Product
- Chapter 10. Company Profiles
- 10.1 Boehringer Ingelheim International Gmbh
- 10.1.1 Company Overview
- 10.1.2 Financial Analysis
- 10.1.3 Regional & Segmental Analysis
- 10.1.4 Research & Development Expenses
- 10.1.5 Recent strategies and developments:
- 10.1.5.1 Partnerships, Collaborations, and Agreements:
- 10.1.6 SWOT Analysis
- 10.2 Bayer AG
- 10.2.1 Company Overview
- 10.2.2 Financial Analysis
- 10.2.3 Segmental and Regional Analysis
- 10.2.4 Research & Development Expense
- 10.2.5 SWOT Analysis
- 10.3 Zoetis, Inc.
- 10.3.1 Company Overview
- 10.3.2 Financial Analysis
- 10.3.3 Regional Analysis
- 10.3.4 Research & Development Expense
- 10.3.5 Recent strategies and developments:
- 10.3.5.1 Acquisition and Mergers:
- 10.3.5.2 Trail and Approvals:
- 10.3.6 SWOT Analysis
- 10.4 Merck & Co., Inc.
- 10.4.1 Company Overview
- 10.4.2 Financial Analysis
- 10.4.3 Segmental and Regional Analysis
- 10.4.4 Research & Development Expenses
- 10.4.5 SWOT Analysis
- 10.5 Elanco Animal Health, Inc.
- 10.5.1 Company Overview
- 10.5.2 Financial Analysis
- 10.5.3 Regional Analysis
- 10.5.4 Research & Development Expense
- 10.5.5 Recent strategies and developments:
- 10.5.5.1 Partnerships, Collaborations, and Agreements:
- 10.5.5.2 Product Launches and Product Expansions:
- 10.5.5.3 Acquisition and Mergers:
- 10.5.6 SWOT Analysis
- 10.6 Zomedica Corp. (Assisi Animal Health)
- 10.6.1 Company Overview
- 10.6.2 Financial Analysis
- 10.6.3 Segmental Analysis
- 10.6.4 Research & Development Expenses
- 10.6.5 SWOT Analysis
- 10.7 Norbrook Laboratories Limited
- 10.7.1 Company Overview
- 10.7.2 SWOT Analysis
- 10.8 Ceva Sante Animale
- 10.8.1 Company Overview
- 10.8.2 SWOT Analysis
- 10.9 Dechra Pharmaceuticals PLC
- 10.9.1 Company Overview
- 10.9.2 Financial Analysis
- 10.9.3 Segmental & Regional Analysis
- 10.9.4 Research & Development Expenses
- 10.9.5 Recent strategies and developments:
- 10.9.5.1 Acquisition and Mergers:
- 10.9.6 SWOT Analysis
- 10.10. Vetoquinol SA (Soparfin SCA)
- 10.10.1 Company Overview
- 10.10.2 Financial Analysis
- 10.10.3 SWOT Analysis
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook